Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625-38].
作者信息
Rosenbloom Arlan L
机构信息
Division of Endocrinology, Department of Pediatrics, College of Medicine, University of Florida, 1701 SW 16th Avenue, Gainesville, FL 32608, USA.
出版信息
Int J Pediatr Endocrinol. 2009;2009:429684. doi: 10.1155/2009/429684. Epub 2010 Feb 8.
Abstract
摘要
相似文献
1
Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625-38].
Int J Pediatr Endocrinol. 2009;2009:429684. doi: 10.1155/2009/429684. Epub 2010 Feb 8.
2
The biosynthesis and secretion of prostate-specific antigen in LNCaP cells.
Cancer Res. 1997 Sep 1;57(17):3830-4.
3
Recycling of glucose and determination of the Cori Cycle and gluconeogenesis.
Am J Physiol. 1999 Sep;277(3):E401-7. doi: 10.1152/ajpendo.1999.277.3.E401.
4
Effects of resistance exercise and growth hormone administration at low doses on lipid metabolism in middle-aged female rats.
Eur J Pharmacol. 2006 Jun 6;539(1-2):99-107. doi: 10.1016/j.ejphar.2006.03.079. Epub 2006 May 9.
5
Leptin concentrations in maternal serum and amniotic fluid during the second trimenon: differential relation to fetal gender and maternal morphometry.
Eur J Obstet Gynecol Reprod Biol. 1999 Oct;86(2):151-7. doi: 10.1016/s0301-2115(99)00059-7.
6
The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients.
Curr Diab Rep. 2016 Mar;16(3):34. doi: 10.1007/s11892-016-0720-z.
7
Activated alveolar macrophages express the insulin-like growth factor-I receptor.
Am J Respir Cell Mol Biol. 1991 May;4(5):432-9. doi: 10.1165/ajrcmb/4.5.432.
8
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
Cancer Res. 1999 May 15;59(10):2370-5.
9
Corrigendum to "Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism" [Diabetes Metab. 41 (2015) 331-337].
Diabetes Metab. 2016 Dec;42(6):e1. doi: 10.1016/j.diabet.2016.10.001. Epub 2016 Nov 16.
10
Oncological complications of excess GH in acromegaly.
Pituitary. 2002 Jan;5(1):21-5. doi: 10.1023/a:1022149300972.
本文引用的文献
1
Idiopathic short stature: conundrums of definition and treatment.
Int J Pediatr Endocrinol. 2009;2009:470378. doi: 10.1155/2009/470378. Epub 2009 Mar 12.
2
Allergic reaction to mecasermin.
Ann Allergy Asthma Immunol. 2009 Jul;103(1):82-3. doi: 10.1016/S1081-1206(10)60150-0.
3
Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins.
Horm Res. 2009;71(2):100-10. doi: 10.1159/000183899. Epub 2009 Jan 8.
4
Anaphylactic reaction to recombinant insulin-like growth factor-I.
J Pediatr Endocrinol Metab. 2008 Apr;21(4):381-4. doi: 10.1515/jpem.2008.21.4.381.
5
Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
Horm Res. 2007;68 Suppl 5:41-7. doi: 10.1159/000110474. Epub 2007 Dec 10.
6
Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
Pediatr Endocrinol Rev. 2007 May;4 Suppl 2:252-71.
7
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6. doi: 10.1210/jc.2007-0204. Epub 2007 Mar 13.
8
Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity.
J Clin Endocrinol Metab. 2007 Mar;92(3):902-10. doi: 10.1210/jc.2006-1610. Epub 2006 Dec 27.
9
Controversy in clinical endocrinology: problems with reclassification of insulin-like growth factor I production and action disorders.
J Clin Endocrinol Metab. 2006 Nov;91(11):4235-6. doi: 10.1210/jc.2006-1641. Epub 2006 Sep 5.
10
Is there a role for recombinant insulin-like growth factor-I in the treatment of idiopathic short stature?
Lancet. 2006 Aug 12;368(9535):612-6. doi: 10.1016/S0140-6736(06)69205-2.
Zotero 插件